0001213900-26-054860
SEC filingTNL Mediagene received a Nasdaq deficiency letter for failing to meet the $2.5 million minimum stockholders' equity requirement, with 45 days to submit a compliance plan.
TNL Mediagene's receipt of the Nasdaq Deficiency Letter signals a critical compliance issue under Listing Rule 5550(b)(1), stemming from stockholders' equity of just $918,088 as reported in its Form 20-F for the year ended December 31, 2025—well below the $2.5 million minimum. Nasdaq also confirmed the Company fails alternative criteria based on market value of listed securities and net income from continuing operations, heightening delisting risk if unaddressed. While no immediate suspension occurs, the 45-day window to June 22, 2026, for submitting a Compliance Plan is tight, with possible 180-day extension only if Nasdaq accepts it. Management's active consideration of options underscores urgency to restore equity levels, potentially via capital raises or operational improvements, to preserve Nasdaq Capital Market listing. This development warrants close investor monitoring, as failure to comply could trigger delisting proceedings, materially impacting liquidity and visibility.